Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Regazzi

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
British Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patientsP Villani, M B Regazzi, F Castelli, et al.
Therapeutic Drug Monitoring|July 31, 2001
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assayP Villani, M Feroggio, L Gianelli, et al.
Transplantation Proceedings|May 30, 2001
Pharmacokinetics of tacrolimus during the early phase after heart transplantationM Molinaro, M B Regazzi, S Pasquino, et al.
Bollettino Chimico Farmaceutico|November 1, 1992
[The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations]M Molinaro, P Villani, I Buggia, et al.
Journal of Chemotherapy (Florence, Italy)|January 5, 2002
Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profileM B Regazzi, E Seminari, P Villani, et al.
The Journal of Rheumatology|September 1, 1993
Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritisA Ravelli, G Di Fuccia, M Molinaro, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2007
A new sensitive enzyme-linked immunosorbent assay (ELISA) for Alemtuzumab determination: development, validation and applicationM Montagna, M A Avanzini, L Visai, et al.
Clinical Pharmacokinetics|October 19, 2001
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIVR Bruno, M B Regazzi, V Ciappina, et al.
Therapeutic Drug Monitoring|June 12, 1999
High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasmaP Villani, M Pregnolato, S Banfo, et al.
The Annals of Pharmacotherapy|March 1, 1995
Efficacy and pharmacokinetics of simvastatin in heart transplant recipientsC Campana, I Iacona, M B Regazzi, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patientsP Villani, M B Regazzi, F Castelli, et al.
Therapeutic Drug Monitoring|July 31, 2001
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assayP Villani, M Feroggio, L Gianelli, et al.
Transplantation Proceedings|May 30, 2001
Pharmacokinetics of tacrolimus during the early phase after heart transplantationM Molinaro, M B Regazzi, S Pasquino, et al.
Bollettino Chimico Farmaceutico|November 1, 1992
[The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations]M Molinaro, P Villani, I Buggia, et al.
Journal of Chemotherapy (Florence, Italy)|January 5, 2002
Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profileM B Regazzi, E Seminari, P Villani, et al.
The Journal of Rheumatology|September 1, 1993
Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritisA Ravelli, G Di Fuccia, M Molinaro, et al.
International Journal of Immunopathology and Pharmacology|July 13, 2007
A new sensitive enzyme-linked immunosorbent assay (ELISA) for Alemtuzumab determination: development, validation and applicationM Montagna, M A Avanzini, L Visai, et al.
Clinical Pharmacokinetics|October 19, 2001
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIVR Bruno, M B Regazzi, V Ciappina, et al.
Therapeutic Drug Monitoring|June 12, 1999
High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasmaP Villani, M Pregnolato, S Banfo, et al.
The Annals of Pharmacotherapy|March 1, 1995
Efficacy and pharmacokinetics of simvastatin in heart transplant recipientsC Campana, I Iacona, M B Regazzi, et al.
Pageof 8